Experimental & Molecular Medicine (EMM) is Korea's first biochemistry journal (founded in 1964) and is relaunched in 1996 as an Open Access, fully peer-reviewed international journal. It is a medical research journal devoted to publishing the latest developments in translational research and the recent discoveries in the biomedical field. Submission is encouraged of papers that involve genetic, molecular and cellular studies of human physiology and diseases. The journal seeks to highlight the improved clinical benefits for human health from experimental and translational research performed using specific molecular tools. Studies that encompass basic discoveries with clinical relevance as well as articles dealing with clear in vivo relevance and novelty will also be welcomed. Experimental & Molecular Medicine is an open access, online-only journal.
Topics of particular interest within the journal's scope include, but are not limited to, those listed below:
Cancer biology
Immunology
Neuroscience
Cardiovascular biology
Genetics and genomics
Gene therapy
Metabolic diseases
Stem cells and regenerative medicine
Physiology and diseases
Molecular Medicine.
《Experimental And Molecular Medicine》是一本由SPRINGERNATURE出版商出版的專業醫學期刊,該刊創刊于1999年,刊期Quarterly,該刊已被國際權威數據庫SCI、SCIE收錄。在中科院最新升級版分區表中,該刊分區信息為大類學科:醫學 2區,小類學科:生化與分子生物學 2區;醫學:研究與實驗 2區;在JCR(Journal Citation Reports)分區等級為Q1。該刊發文范圍涵蓋生化與分子生物學等領域,旨在及時、準確、全面地報道國內外生化與分子生物學工作者在該領域取得的最新研究成果、工作進展及學術動態、技術革新等,促進學術交流,鼓勵學術創新。2021年影響因子為12.153,平均審稿速度平均3月。
大類學科 | 分區 | 小類學科 | 分區 | Top期刊 | 綜述期刊 |
醫學 | 2區 | BIOCHEMISTRY & MOLECULAR BIOLOGY 生化與分子生物學 MEDICINE, RESEARCH & EXPERIMENTAL 醫學:研究與實驗 | 2區 2區 | 否 | 否 |
JCR分區等級 | JCR所屬學科 | 分區 | 影響因子 |
Q1 | MEDICINE, RESEARCH & EXPERIMENTAL | Q1 | 12.153 |
BIOCHEMISTRY & MOLECULAR BIOLOGY | Q1 |
影響因子 | h-index | Gold OA文章占比 | 研究類文章占比 | OA開放訪問 | 平均審稿速度 |
12.153 | 68 | 100.00% | 63.58% | 開放 | 平均3月 |